Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021

por Yao Rodion Konu, Fifonsi Adjidossi Gbeasor-Komlanvi, Mouhoudine Yerima, Arnold Junior Sadio, Martin Kouame Tchankoni, Wendpouire Ida Carine Zida-Compaore, Josée Nayo-Apetsianyi, Kossivi Agbélénko Afanvi, Sibabe Agoro, Mounerou Salou, Dadja Essoya Landoh, Atany B. Nyansa, Essohanam Boko, Moustafa Mijiyawa, Didier Koumavi Ekouevi
Publicado 2021